HOME >> BIOLOGY >> NEWS
Progesterone therapy and preterm birth: More evidence helps identify women who can benefit

WHITE PLAINS, N.Y., AUG. 2, 2005 Two major studies published today in The New England Journal of Medicine can help doctors better identify pregnant women at risk for preterm delivery who can benefit from progesterone treatment, the March of Dimes Foundation said today.

In one large multi-center trial led by Eduardo B. Fonseca, M.D., women with short cervix (most of whom had no prior history of preterm birth) who received progesterone suppository treatment between 24 and 34 weeks gestation had a greatly reduced rate of preterm birth.

Another large multi-center trial led by Dwight J. Rouse, M.D., found that weekly injections of 17P (17 alpha-hydroxyprogesterone caproate, a derivative of progesterone) between 16 and 35 weeks gestation did not reduce the rate of preterm birth among women carrying twins.

Premature birth is a growing problem in the United States and a leading killer of newborns, said Michael Katz, senior vice president for Research and Global Programs of the March of Dimes. With this new information, physicians will have a better idea of how to identify those women who are most likely to benefit from progesterone treatment from those who are not.

Dr. Katz noted that pathways to preterm birth may differ substantially between singleton and twin gestations. For example, progesterone may be more effective against some pathway that does not involve the uterine over-distention seen in twin pregnancy.

We need more research into the underlying causes of prematurity to help women with other risk factors, Dr. Katz said.


'"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
1-Aug-2007


Page: 1

Related biology news :

1. Progesterone injections do not prevent preterm birth in twin pregnancies
2. Testosterone replacement therapy: How safe for aging men?
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2018)... ... August 29, 2018 , ... ... non-invasive technology to identify specific chromosomal abnormalities using morphological assessment through artificial ... and Australia-based Life Whisperer suggests that artificial intelligence (AI) ...
(Date:8/23/2018)... ... August 21, 2018 , ... CRISPR-Cas9 gene ... types and species for the robust functional interrogation of complex biological processes. Gene ... T-cell based immunotherapies, the study of the autoimmunity, the understanding of host-pathogen dynamics ...
(Date:8/21/2018)... ... 21, 2018 , ... Whether it be online or through ... offering customers a successful experience. When browsing the new site in search ... with relevant details such as technical manuals, application notes, and instrument compatibility readily ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... YORBA LINDA, Calif. (PRWEB) , ... August 28, 2018 , ... ... engineers, and scientists from around the world, is proud to announce the launch of ... events LabRoots offers for a chance to win one of LabRoots most popular shirts. ...
(Date:8/26/2018)... , ... August 24, 2018 , ... ... that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a variety of ... According to the paper, the symptoms of mice having severe atopic dermatitis were ...
(Date:8/21/2018)... (PRWEB) , ... August 21, ... ... a software company specializing in medical device compliance and commercialization, has just ... Cockpit® platform. , Written and presented by Dr. Mario Kossmann, ESEP at ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical and Biomarker Services, ... of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of BioPharma. ... group that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. Dr. ...
Breaking Biology Technology:
Cached News: